Development of a chemiluminescence immunoassay using recombinant non-structural epitope-based proteins to accurately differentiate foot-and-mouth disease virus-infected and vaccinated bovines.

about

Development of a chemiluminescence immunoassay using recombinant non-structural epitope-based proteins to accurately differentiate foot-and-mouth disease virus-infected and vaccinated bovines.

Item

http://www.wikidata.org/entity/Q47552536

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Development of a chemiluminesc ...... fected and vaccinated bovines.

@en

Development of a chemiluminesc ...... fected and vaccinated bovines.

@nl

type

Item

label

Development of a chemiluminesc ...... fected and vaccinated bovines.

@en

Development of a chemiluminesc ...... fected and vaccinated bovines.

@nl

prefLabel

Development of a chemiluminesc ...... fected and vaccinated bovines.

@en

Development of a chemiluminesc ...... fected and vaccinated bovines.

@nl

P1476

Development of a chemiluminesc ...... nfected and vaccinated bovines

@en

P2093

H-Y Chang

http://www.w3.org/2001/XMLSchema#string

J-J Shao

http://www.w3.org/2001/XMLSchema#string

S-D Gao

http://www.w3.org/2001/XMLSchema#string

Y-G Zhang

http://www.w3.org/2001/XMLSchema#string

Z-Z Liu

http://www.w3.org/2001/XMLSchema#string

P2860

An overview on ELISA techniques for FMD.

Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.

Development of a competitive enzyme-linked immunosorbent assay for detection of antibodies against the 3B protein of foot-and-mouth disease virus.

Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease.

Pan-Serotype Diagnostic for Foot-and-Mouth Disease Using the Consensus Antigen of Nonstructural Protein 3B.

Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle.

Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.

A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.

Within herd transmission and evaluation of the performance of clinical and serological diagnosis of foot-and-mouth disease in partially immune cattle herds.

Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle

P304

338-344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TBED.12811

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fu-Rong Zhao

P577

2018-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29341485

http://www.w3.org/2001/XMLSchema#string